Effekt Von Gewichtsabnahme Auf Die zentralnervöse Insulinresistenz Des Menschen

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Obesity if known to be associated with brain insulin resistance in humans. This condition has not only implication for the brain but also for whole-body energy homeostasis. Research in rodents indicates that weight loss is able to improve insulin sensitivity of the brain. The current project will test this hypothesis in humans. Therefore, brain insulin sensitivity will be assessed by fMRI in combination with intranasal insulin administration, using an established protocol. Furthermore, effects of daily administration of insulin nasal spray (versus placebo) over 8 weeks will be assessed as secondary (exploratory) variables.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 75
Healthy Volunteers: t
View:

• HbA1c \<6.5%

• Age between 40 and 75 years

• No intake of antidiabetic drugs or drugs for weight reduction

• no steroid intake

• Stable medication over 10 weeks before the start of the study

Locations
Other Locations
Germany
University of Tuebingen, Department of Internal Medicine IV
RECRUITING
Tübingen
Contact Information
Primary
Andreas Fritsche, MD
andreas.fritsche@med.uni-tuebingen.de
+49 7071 29 80687
Time Frame
Start Date: 2016-12
Estimated Completion Date: 2024-12
Participants
Target number of participants: 40
Treatments
Active_comparator: nasal insulin
daily administration of 160 U of human insulin as nasal spray
Placebo_comparator: placebo spray
daily administration of placebo solution as nasal spray
Related Therapeutic Areas
Sponsors
Leads: University Hospital Tuebingen

This content was sourced from clinicaltrials.gov